DAVID J. GRAINGER - Chief Innovation Officer at Centessa Pharmaceuticals plc

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Innovation Officer
Issuer Symbol
CNTA on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by DAVID J. GRAINGER since 11 Mar 2025

Holdings reported by DAVID J. GRAINGER for Centessa Pharmaceuticals plc

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Ordinary Shares 962,790 $7,663,808 $7.96 31 Dec 2023 Direct
Ordinary Shares 27,500 $218,900 $7.96 31 Dec 2023 Indirect

Transactions reported by DAVID J. GRAINGER for Centessa Pharmaceuticals plc

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.